HANS REISINGER: Open Payments
NPI 1679973044 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 25 payments from 12 companies in 2025. Trend: 2023 $424 · 2024 $615 · 2025 $632
Food & beverage: $632
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $174 |
| ABBVIE INC. | 6 | $149 |
| Phathom Pharmaceuticals, Inc. | 3 | $81 |
| Ardelyx, Inc. | 2 | $62 |
| Novo Nordisk Inc | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Abbott Laboratories | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
Products named: TREMFYA, QULIPTA, VOQUEZNA, IBSRELA, RINVOQ, SKYRIZI, CAMZYOS, Wegovy.
Industry payments across PA — which companies pay providers there.
